NOVO NORDISK

MixPro® and NovoSeven® are registered trademarks of Novo Nordisk Health Care AG. Novo Nordisk is a registered trademark of Novo Nordisk A/S... NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medication used to treat bleeding in hemophilia A or B with inhibitors, congenital FVII deficiency, and Glanzmann's thrombasthenia when platelets don't work, and adults with acquired hemophilia. See Safety Information and Prescribing Information... Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported

Also known as: NovoSeven RT

Primary location: Plainsboro United States